Altogether, these data suggest that both drugs may reverse CLND effect on primary tumor growth in RET mice by interfering with the activation state of the kinase AKT and the balance between anti-apoptotic and pro-apoptotic genes. The gene discussed is AKT1; the disease is neoplasm.